Precursor Cell Lymphoblastic Leukemia-Lymphoma
"Precursor Cell Lymphoblastic Leukemia-Lymphoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. It is the most common cancer in children and accounts for the vast majority of all childhood leukemias.
MeSH Number(s)
C04.557.337.428.600
C15.604.515.560.600
C20.683.515.528.600
Concept/Terms
Precursor Cell Lymphoblastic Leukemia-Lymphoma- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Precursor Cell Lymphoblastic Leukemia Lymphoma
- Leukemia, Lymphoblastic
- Leukemia, Lymphoblastic, Acute
- Leukemia, Lymphocytic, Acute
- Lymphoma, Lymphoblastic
- Lymphoblastic Leukemia
- Lymphoblastic Leukemia, Acute
- Acute Lymphoblastic Leukemia
- Leukemia, Acute Lymphoblastic
- Lymphoblastic Lymphoma
- Lymphomas, Lymphoblastic
- Lymphocytic Leukemia, Acute
- Acute Lymphocytic Leukemia
- Leukemia, Acute Lymphocytic
- Acute Lymphoid Leukemia
- Leukemia, Acute Lymphoid
- Lymphoid Leukemia, Acute
- Leukemia, Lymphoid, Acute
Leukemia, Lymphocytic, Acute, L1- Leukemia, Lymphocytic, Acute, L1
- Lymphocytic Leukemia, L1
- L1 Lymphocytic Leukemia
- Leukemia, L1 Lymphocytic
- Lymphoblastic Leukemia, Acute, Childhood
- Lymphoblastic Leukemia, Acute, L1
- ALL, Childhood
- Childhood ALL
- Leukemia, Lymphoblastic, Acute, L1
Leukemia, Lymphocytic, Acute, L2- Leukemia, Lymphocytic, Acute, L2
- Lymphocytic Leukemia, L2
- L2 Lymphocytic Leukemia
- Leukemia, L2 Lymphocytic
- Lymphoblastic Leukemia, Acute, Adult
- Lymphoblastic Leukemia, Acute, L2
- Leukemia, Lymphoblastic, Acute, L2
- Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
Below are MeSH descriptors whose meaning is more general than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
Below are MeSH descriptors whose meaning is more specific than "Precursor Cell Lymphoblastic Leukemia-Lymphoma".
This graph shows the total number of publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Harvard Catalyst Profiles by year, and whether "Precursor Cell Lymphoblastic Leukemia-Lymphoma" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1992 | 11 | 4 | 15 |
| 1993 | 8 | 6 | 14 |
| 1994 | 12 | 2 | 14 |
| 1995 | 13 | 5 | 18 |
| 1996 | 12 | 2 | 14 |
| 1997 | 15 | 4 | 19 |
| 1998 | 11 | 2 | 13 |
| 1999 | 7 | 1 | 8 |
| 2000 | 12 | 2 | 14 |
| 2001 | 13 | 3 | 16 |
| 2002 | 11 | 3 | 14 |
| 2003 | 14 | 3 | 17 |
| 2004 | 14 | 2 | 16 |
| 2005 | 19 | 4 | 23 |
| 2006 | 17 | 6 | 23 |
| 2007 | 22 | 5 | 27 |
| 2008 | 12 | 11 | 23 |
| 2009 | 20 | 3 | 23 |
| 2010 | 20 | 5 | 25 |
| 2011 | 20 | 5 | 25 |
| 2012 | 21 | 2 | 23 |
| 2013 | 20 | 2 | 22 |
| 2014 | 29 | 3 | 32 |
| 2015 | 21 | 2 | 23 |
| 2016 | 36 | 5 | 41 |
| 2017 | 25 | 5 | 30 |
| 2018 | 32 | 0 | 32 |
| 2019 | 35 | 3 | 38 |
| 2020 | 39 | 1 | 40 |
| 2021 | 41 | 1 | 42 |
| 2022 | 4 | 0 | 4 |
Below are the most recent publications written about "Precursor Cell Lymphoblastic Leukemia-Lymphoma" by people in Profiles.
-
Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell-like blasts in KMT2A-rearranged leukemia. Blood. 2022 Apr 07; 139(14):2198-2211.
-
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium Trials. Blood Adv. 2022 01 11; 6(1):72-81.
-
Retrospective analysis of arterial occlusive events in the PACE trial by an independent adjudication committee. J Hematol Oncol. 2022 01 06; 15(1):1.
-
Barriers to Care and Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment in the Gaza Strip. J Pediatr Hematol Oncol. 2022 01 01; 44(1):e123-e126.
-
Acute lymphoblastic leukemia in older adults: curtain call for conventional chemotherapy? Hematology Am Soc Hematol Educ Program. 2021 12 10; 2021(1):7-14.
-
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL. Blood Adv. 2021 11 23; 5(22):4691-4700.
-
Minimal residual disease and outcome characteristics in infant KMT2A-germline acute lymphoblastic leukaemia treated on the Interfant-06 protocol. Eur J Cancer. 2022 01; 160:72-79.
-
Microenvironmental IL-6 inhibits anti-cancer immune responses generated by cytotoxic chemotherapy. Nat Commun. 2021 10 28; 12(1):6218.
-
Impact of Risk-Stratified Therapy on Health Status in Survivors of Childhood Acute Lymphoblastic Leukemia: A Report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2022 01; 31(1):150-160.
-
Comparative study of therapy-related and de novo adult b-cell acute lymphoblastic leukaemia. Br J Haematol. 2022 02; 196(4):963-968.